News
[Report] WHO: Global health gains face threat of reversal
9+ hour, 40+ min ago (203+ words) European AIDS Treatment Group [Report] WHO: Global health gains face threat of reversal The World Health Organization (WHO) published the World Health Statistics 2026 report showing the world is falling short on health targets, with progress uneven, slowing, and in some…...
The Aid Report: A shock to the system: Global health after US aid cuts
9+ hour, 45+ min ago (205+ words) [Report] The Aid Report: A shock to the system: Global health after US aid cuts European AIDS Treatment Group [Report] The Aid Report: A shock to the system: Global health after US aid cuts Global health report by The Aid…...
CATIE: British Columbia study underscores the importance of the shingles vaccine for people with HIV
4+ day, 11+ hour ago (208+ words) European AIDS Treatment Group CATIE: British Columbia study underscores the importance of the shingles vaccine for people with HIV Scientists analyzed health-related information collected from more than 18, 000 adults, half of whom had HIV. The researchers found that people with HIV…...
[BHIVA/BASHH 2026] aidsmap: UK sexual health conference debates move to less frequent STI screening
4+ day, 10+ hour ago (171+ words) European AIDS Treatment Group [BHIVA/BASHH 2026] aidsmap: UK sexual health conference debates move to less frequent STI screening aidsmap report from the 6th Joint Conference of the British HIV Association (BHIVA) and the British Association for Sexual Health and HIV (BASHH)…...
Infectious Disease Advisor: Dolutegravir plus lamivudine maintains HIV-1 suppression without HBV reactivation
4+ day, 11+ hour ago (143+ words) European AIDS Treatment Group Infectious Disease Advisor: Dolutegravir plus lamivudine maintains HIV-1 suppression without HBV reactivation Among adults with HIV-1 and prior hepatitis B virus (HBV) exposure, treatment with dolutegravir plus lamivudine (DTG/3 TC) is associated with high rates of…...
Caring Cross announces promising clinical data with single-dose anti-HIV CAR-T cell therapy
4+ day, 12+ hour ago (155+ words) European AIDS Treatment Group Caring Cross announces promising clinical data with single-dose anti-HIV CAR-T cell therapy Caring Cross announced early clinical data from a first-in-human Phase I/IIa trial of a novel CAR-T cell strategy in people living with HIV....
The Rockefeller University: Researchers track the mutations that allow HIV-1 to escape broadly neutralizing antibodies
4+ day, 13+ hour ago (228+ words) European AIDS Treatment Group The Rockefeller University: Researchers track the mutations that allow HIV-1 to escape broadly neutralizing antibodies Broadly neutralizing antibodies (b NAbs) are among the most promising new treatments for HIV, offering the potential to forego the traditional…...
[Press release] Vii V Healthcare aims to close treatment gaps for children living with HIV with paediatric Dovato marketing applications to the EMA and FDA
4+ day, 13+ hour ago (197+ words) European AIDS Treatment Group [Press release] Vii V Healthcare aims to close treatment gaps for children living with HIV with paediatric Dovato marketing applications to the EMA and FDA London, 11 May 2026 " Vii V Healthcare, the global specialist HIV company majority…...
[BHIVA/BASHH 2026] aidsmap: People living with HIV join outreach teams as re-engagement in care moves up the political agenda
1+ week, 11+ hour ago (225+ words) European AIDS Treatment Group [BHIVA/BASHH 2026] aidsmap: People living with HIV join outreach teams as re-engagement in care moves up the political agenda aidsmap report from the 6th Joint Conference of the British HIV Association (BHIVA) and the British Association for…...
HIV i-Base: Immune-based research into finding a cure for HIV
1+ week, 12+ hour ago (201+ words) European AIDS Treatment Group HIV i-Base: Immune-based research into finding a cure for HIV An excellent review of research using immune-based approaches to cure HIV is published as an open access article in the May 2026 issue of the journal Drugs....